Xaira Therapeutics
Integrated biotechnology company focusing on leveraging artificial intelligence to transform drug discovery and development.
Launch date
Employees
Market cap
-
Enterprise valuation
€3.6—5.5b (Dealroom.co estimates Apr 2024.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Spinout | |
* | $1.0b | Late VC | |
Total Funding | €909m |